J0614 — Injection, treosulfan, 50 mg
J0614 is a HCPCS Level II code for injection, treosulfan, 50 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
Medically Unlikely Edits — units per day
The most units of J0614 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.
- practitioner
- 600 units MAI 3 — Date of Service Edit: Clinical · Prescribing Information
- outpatient
- 600 units MAI 3 — Date of Service Edit: Clinical · Prescribing Information
The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.
The CMS record for J0614
- Long descriptor
- Injection, treosulfan, 50 mg
- Short descriptor
- Inj, treosulfan, 50 mg
- Added
- October 1, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0614
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0614 is not quite right, the correct code is very often within a few positions of it.
- J0606Injection, etelcalcetide, 0.1 mg
- J0607Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
- J0608Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
- J0609Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
- J0610Injection, calcium gluconate (fresenius kabi), per 10 mlterminated
- J0611Injection, calcium gluconate (wg critical care), per 10 mlterminated
- J0612Injection, calcium gluconate, not otherwise specified, 10 mg
- J0613Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
- J0615Calcium acetate, oral, 23 mg (for esrd on dialysis)
- J0616Injection, metoprolol tartrate, 1 mg
- J0618Injection, calcium chloride, 2 mg
- J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml
- J0630Injection, calcitonin salmon, up to 400 units
- J0636Injection, calcitriol, 0.1 mcg
- J0637Injection, caspofungin acetate, 5 mg
- J0638Injection, canakinumab, 1 mg
Questions about J0614
What is HCPCS code J0614?
J0614 is a HCPCS Level II code for injection, treosulfan, 50 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0614?
The CMS HCPCS file marks J0614 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J0614 paid under the physician fee schedule?
J0614 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).